Veriti Management LLC Raises Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Veriti Management LLC boosted its holdings in Mettler-Toledo International Inc. (NYSE:MTDGet Rating) by 5.1% in the first quarter, HoldingsChannel reports. The institutional investor owned 706 shares of the medical instruments supplier’s stock after purchasing an additional 34 shares during the quarter. Veriti Management LLC’s holdings in Mettler-Toledo International were worth $969,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of MTD. CVA Family Office LLC purchased a new stake in Mettler-Toledo International in the 4th quarter worth $25,000. Rockbridge Investment Management LCC purchased a new stake in Mettler-Toledo International in the 4th quarter worth $25,000. Amplius Wealth Advisors LLC purchased a new stake in Mettler-Toledo International in the 4th quarter worth $39,000. Moors & Cabot Inc. purchased a new stake in Mettler-Toledo International in the 3rd quarter worth $51,000. Finally, Glassman Wealth Services increased its stake in Mettler-Toledo International by 57.9% in the 4th quarter. Glassman Wealth Services now owns 30 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 11 shares in the last quarter. Institutional investors and hedge funds own 93.88% of the company’s stock.

In other news, Director Wah-Hui Chu sold 56 shares of the business’s stock in a transaction that occurred on Friday, May 27th. The stock was sold at an average price of $1,308.00, for a total transaction of $73,248.00. Following the transaction, the director now owns 3,719 shares of the company’s stock, valued at approximately $4,864,452. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Shawn Vadala sold 400 shares of the business’s stock in a transaction that occurred on Monday, May 23rd. The shares were sold at an average price of $1,245.00, for a total value of $498,000.00. Following the transaction, the chief financial officer now directly owns 4,900 shares in the company, valued at approximately $6,100,500. The disclosure for this sale can be found here. In the last three months, insiders have sold 38,571 shares of company stock worth $48,377,720. Corporate insiders own 2.80% of the company’s stock.

NYSE:MTD opened at $1,101.73 on Thursday. The company has a debt-to-equity ratio of 20.89, a current ratio of 1.20 and a quick ratio of 0.79. Mettler-Toledo International Inc. has a 1 year low of $1,082.78 and a 1 year high of $1,714.75. The stock’s 50 day simple moving average is $1,252.55 and its two-hundred day simple moving average is $1,394.02. The company has a market cap of $25.05 billion, a price-to-earnings ratio of 32.36, a PEG ratio of 1.50 and a beta of 1.06.

Mettler-Toledo International (NYSE:MTDGet Rating) last released its quarterly earnings data on Thursday, May 5th. The medical instruments supplier reported $7.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.32 by $0.55. The business had revenue of $897.80 million for the quarter, compared to the consensus estimate of $868.08 million. Mettler-Toledo International had a return on equity of 540.97% and a net margin of 20.82%. The company’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.56 EPS. As a group, analysts anticipate that Mettler-Toledo International Inc. will post 38.35 EPS for the current year.

A number of brokerages have recently weighed in on MTD. StockNews.com started coverage on Mettler-Toledo International in a research report on Thursday, March 31st. They set a “buy” rating for the company. Wells Fargo & Company raised Mettler-Toledo International from an “equal weight” rating to an “overweight” rating and reduced their price objective for the stock from $1,600.00 to $1,410.00 in a research note on Monday, April 25th. Finally, The Goldman Sachs Group downgraded Mettler-Toledo International from a “neutral” rating to a “sell” rating and set a $1,240.00 price objective on the stock. in a research note on Thursday, March 10th.

Mettler-Toledo International Company Profile (Get Rating)

Mettler-Toledo International Inc engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDGet Rating).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.